-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2011 to 2024.
- Integrated Biopharma Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was $657K, a 50% decline year-over-year.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was $943K, a 23.5% decline from 2023.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $1.23M, a 69.9% decline from 2022.
- Integrated Biopharma Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was $4.09M, a 34.1% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)